<DOC>
	<DOCNO>NCT01754129</DOCNO>
	<brief_summary>In patient advanced levodopa-responsive Parkinson 's Disease severe motor fluctuation despite optimized treatment conventional oral Parkinson 's Disease medication , treatment Duodopa represent alternative treatment option improve motor , non-motor performance overall quality life . These benefit obtain short mid-term trial ( mainly 2 year ) . Data long-term effectiveness ( 5 year treatment ) safety available . Also data concern benefit Duodopa cognitive function , axial symptom disability confirm . Recent data deep brain stimulation ( DBS ) , alternative option treatment advance Parkinson 's Disease patient , show 5 year implant , worsen axial symptom ( gait balance ) 1 3 year speech could occur . Moreover , never assess benefit motor non-motor symptom patient treat DUODOPA could influence age duration disease , already show DBS implanted patient . This study clarify miss information long-term benefit Duodopa ( 7 year ) especially focus motor fluctuation disability .</brief_summary>
	<brief_title>Global REsponsE During iNFusIon gEl With LevoDopa/Carbidopa</brief_title>
	<detailed_description>Post Marketing Observational Study document long-term clinical effectiveness DUODOPA Parkinson Disease patient condition routine clinical setting .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Patients already treatment DUODOPA ® ( already conclude nasointestinal phase ) accord local DUODOPA® product label clinical routine care advance PD patient Patients available data Duodopa treatment , previous PD conventional treatment least one scales/questionnaires study already collect patient clinical chart Patient legal representative give write informed consent Nonprofessional caregiver ( relative familiar give daily assistance patient ) give his/her write consent • History presence condition might interfere longterm continuation duodenal infusion DUODOPA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Caregiver</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>